Daniel Gottlieb

Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA.

Guidant Compass Group (Guidant Compass Group) is a venture capital subsidiary of Boston Scientific Corp. founded in 1994. The firm is headquartered in Santa Clara, California.

Broadview Ventures, Inc. (Broadview Ventures) is a venture capital firm founded in 2008. The firm is headquartered in Boston, Massachusetts.

Part of Abbott Laboratories, Abbott Vascular, Inc. is a company that manufactures cardiac and vascular care systems. The company is based in Abbott Park, IL.

XII Medical, Inc. develops software for monitoring and analyzing sleep. The company is based in Cleveland, OH and has subsidiaries in the United States.

The American company's platform leverages novel, multi-sensor devices and proprietary algorithms to mine raw biosignals for unprecedented visibility into cardiac function. Cardiosense has developed an advanced signal processing pipeline to identify pre-symptomatic markers of cardiac disease, and has introduced an end-to-end patient monitoring and sensor analytics ecosystem that includes the Cardiotag sensor, a medical-grade, multi-sensor wearable device for wireless patient monitoring from in-hospital to home, and the Wavesense platform, a device-agnostic software to enable aggregation, transmission, and analytics of physiological sensor data. The company has also developed clinical AI digital biomarkers for early disease detection by applying deep learning to raw physiological waveforms. Amit K. Gupta has been the CEO of the company since 2020.